In AD, PDGFRβ signalling disruption resulting from the cleavage of the extracellular domain of PDGFRβ into the CSF is strongly correlated with BBB permeability, hypoperfusion and cognitive impairment7,8,12. This evidence concerns the gene PDGFRB and Alzheimer disease.